IBOV 168,180.39 ▼ 0.59% IPC MEX 69,787.41 ▲ 0.87% MERVAL 2,848,945 — — USD/BRL5.40▲ 0.43% USD/MXN18.78▼ 0.47% USD/CLP991.33▲ 0.31% USD/COP3,169▲ 0.06% USD/PEN3.46▼ 0.03% USD/ARS1,536▼ 0.20% USD/UYU40.19▲ 3.18% USD/PYG5,965▲ 5.35% USD/BOB12.07▲ 3.37% USD/DOP60.08▼ 0.07% USD/CRC451.45▲ 2.56% USD/GTQ7.64▲ 3.29% USD/HNL26.88▲ 0.49% USD/NIO36.62▲ 0.07% USD/VES887.03▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD158.53▲ 3.24% USD/TTD6.71▲ 2.13% EUR/BRL6.03▲ 1.20% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99% IBOV 168,180.39 ▼ 0.59% IPC MEX 69,787.41 ▲ 0.87% MERVAL 2,848,945 — — USD/BRL 5.34 ▼ 1.32% USD/MXN 18.69 ▲ 0.62% USD/CLP 983.47 ▼ 0.57% USD/COP 3,149 ▲ 3.06% USD/PEN 3.45 ▲ 0.17% USD/ARS 1,537 ▼ 0.28% USD/UYU 40.21 ▲ 3.57% USD/PYG 5,803 ▲ 3.78% USD/BOB 11.97 ▲ 4.93% USD/DOP 60.54 ▲ 1.83% USD/CRC 451.24 ▲ 2.13% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.87 ▲ 3.37% USD/NIO 36.62 ▲ 2.81% USD/VES 885.08 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.63% USD/TTD 6.71 ▲ 2.07% EUR/BRL 5.95 ▲ 7.53% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99%
since 2009
Friday, October 30, 2026

Covid-19 Brazil

Covid-19: Johnson & Johnson to Conduct Vaccine Trials in Brazil

By · August 18, 2020 · 2 min read

RIO DE JANEIRO, BRAZIL – The National Technical Committee on Biosafety – CTNBio has just approved the clinical protocol, submitted by Janssen, Johnson & Johnson’s pharmaceutical arm, for conducting the phase 3 clinical trial (the last stage of a research) of the vaccine against the novel coronavirus in Brazil.

The third phase of clinical trials is expected to begin in September. The authorization request for the trial will also be analyzed by other bodies, such as ANVISA (National Health REgulatory Agency) and CONEP (National Research Ethics Committee).

Ad26.COV2.S, the name given to the vaccine developed by Johnson, is considered one of the most promising against the disease and is part of the American government’s incentive program. The last stage of the vaccine’s testing is expected to include 60,000 healthy volunteers between the ages of 18 and 60.

The National Technical Committee on Biosafety - CTNBio has just approved the clinical protocol, submitted by Janssen, Johnson & Johnson's pharmaceutical arm, for conducting the phase 3 clinical trial of the vaccine against the novel coronavirus in Brazil (the last stage of a research).
Brazil’s National Technical Committee on Biosafety – CTNBio has just approved the clinical protocol, submitted by Johnson & Johnson’s pharmaceutical arm, for conducting the phase 3 clinical trial of the vaccine against the novel coronavirus in Brazil.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

According to data on the study registered on clinicaltrials.org, there will be 178 study centers located in nine countries: the United States, Brazil, Chile, Colombia, Mexico, Peru, the Philippines, South Africa and Ukraine. In Brazil, there are 22 institutions involved, located in São Paulo, São José do Rio Preto, Salvador, Rio de Janeiro, Porto Alegre, Natal, Curitiba, Campinas, Brasília, Belo Horizonte and Barretos.

“The decision on which countries will be involved in the study considers the current prevalence of the disease, population demographics and regulatory authorities’ requirements, to ensure that the study can be conducted appropriately and produce relevant data on vaccine safety and efficacy,” says the laboratory. Brazil’s rolling daily average of cases and deaths now stands at 43,157.1 and 969.1, respectively.

Source: Veja

This article was drafted with automated assistance and reviewed before publication. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

All News Brazil art news Brazil Best English News Brazil Best News Brazil Brazil Brazil economy Brazil football Brazil Museum Fire Brazil national football team Brazil News Brazil Pension Reform Brazil Real Brazil Visa Brazilian Newspaper Business News Brazil Covid-19 Latin America culture news Brazil English Culture News Brazil English Info Brazil English Info Rio de Janeiro English News Argentina English News Belo Horizonte English News Bolivia English News Brasilia English News Brazil English News Chile English News Colombia English News Cuba English News Curitiba English News Ecuador English News El Salvador English News Falklands English News Florianopolis English News Guetamala English News Latin America English News Mexico English News Panama English News Paraguay English News Peru English News Rio de Janeiro English News Sao Paulo English News Uruguay English News Venezuela English Newspaper Brazil English Newspaper Rio de Janeiro Falkland Islands General News Brazil Info Brazil Info Rio de Janeiro Invest in Brazil Mining News Brazil Natioal Museum of Brazil News Argentina News Bolivia News Brasilia news Brazil News Chile News Colombia News Cuba News Ecuador News El Salvador News Falklands News Florianopolis News Guatemala News Latin America News Mexico News Panama News Paraguay News Peru News Rio de Janeiro News Uruguay News Venezuela Oil News Brazil President of Brazil Rio de Janeiro São Paulo News Science News Brazil travel Brazil Travel News Brazil Universities Brazil

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.